lletermovir prophylaxis

Letermovir (917389-32-3) Letermovir is an antiviral agent administered orally or intravenously that functions as a cytomegalovirus terminus complex inhibitor. It is specifically used in the treatment of CMV infection, which commonly affects individuals with immunocompromised systems. Product Specifications Product Name: Letermovir CAS No.: 917389-32-3 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C29H28F4N4O4 Molecular Weight: 572.55 Shelf Life: 2